Analysis and Commentary STEVEN GROSSMAN 6/2/23 Analysis and Commentary STEVEN GROSSMAN 6/2/23 The Budget Deal - First Impressions from an FDA Perspective Read More Analysis and Commentary STEVEN GROSSMAN 5/19/23 Analysis and Commentary STEVEN GROSSMAN 5/19/23 The Macro- and Micro- Budget Processes and Their Impact on FDA Resources Read More Analysis and Commentary STEVEN GROSSMAN 5/12/23 Analysis and Commentary STEVEN GROSSMAN 5/12/23 FDA and the Iron Triangle of Deficit Reduction Read More Analysis and Commentary STEVEN GROSSMAN 5/5/23 Analysis and Commentary STEVEN GROSSMAN 5/5/23 Hill Days and the Bumpy FY 24 Appropriations Cycle Read More Analysis and Commentary STEVEN GROSSMAN 4/28/23 Analysis and Commentary STEVEN GROSSMAN 4/28/23 Top Ten Challenges Facing FDA Read More Analysis and Commentary STEVEN GROSSMAN 4/21/23 Analysis and Commentary STEVEN GROSSMAN 4/21/23 Q&A About FDA and the FY 24 Budget/Appropriations Process Read More Analysis and Commentary STEVEN GROSSMAN 4/14/23 Analysis and Commentary STEVEN GROSSMAN 4/14/23 Alliance Testifies to the House and Senate on FY 24 Appropriations Read More Analysis and Commentary STEVEN GROSSMAN 4/6/23 Analysis and Commentary STEVEN GROSSMAN 4/6/23 FDA’s FY 24 Budget Q&A Read More Analysis and Commentary STEVEN GROSSMAN 3/31/23 Analysis and Commentary STEVEN GROSSMAN 3/31/23 Why Participate In Hill Days Read More Analysis and Commentary STEVEN GROSSMAN 3/24/23 Analysis and Commentary STEVEN GROSSMAN 3/24/23 Answers to Your Questions about FY24 Appropriation Read More Analysis and Commentary STEVEN GROSSMAN 3/17/23 Analysis and Commentary STEVEN GROSSMAN 3/17/23 Alliance Seeks Input on FDA Budget Read More Analysis and Commentary STEVEN GROSSMAN 3/10/23 Analysis and Commentary STEVEN GROSSMAN 3/10/23 More Details on the Administration’s FDA Budget Read More Analysis and Commentary STEVEN GROSSMAN 3/3/23 Analysis and Commentary STEVEN GROSSMAN 3/3/23 Looking Ahead to the President’s Budget, Part II Read More Analysis and Commentary STEVEN GROSSMAN 3/1/23 Analysis and Commentary STEVEN GROSSMAN 3/1/23 Looking Ahead to the Presidents FY24 Budget Request Read More Analysis and Commentary STEVEN GROSSMAN 2/17/23 Analysis and Commentary STEVEN GROSSMAN 2/17/23 What Dr. Califf Told Us During His Fireside Chat Read More Analysis and Commentary STEVEN GROSSMAN 2/10/23 Analysis and Commentary STEVEN GROSSMAN 2/10/23 Q&A on Medical and Food Safety Advocacy Read More Analysis and Commentary STEVEN GROSSMAN 2/3/23 Analysis and Commentary STEVEN GROSSMAN 2/3/23 The President’s FY24 Budget Request and the Appropriations Cycle Read More Analysis and Commentary STEVEN GROSSMAN 1/27/23 Analysis and Commentary STEVEN GROSSMAN 1/27/23 What the Alliance Told the Commissioner About Food Safety Read More Analysis and Commentary STEVEN GROSSMAN 1/20/23 Analysis and Commentary STEVEN GROSSMAN 1/20/23 What is the Latest in FDA Policy, Legislation, and International Affairs? Read More Analysis and Commentary STEVEN GROSSMAN 1/13/23 Analysis and Commentary STEVEN GROSSMAN 1/13/23 A Separate Food Agency? Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 6/2/23 Analysis and Commentary STEVEN GROSSMAN 6/2/23 The Budget Deal - First Impressions from an FDA Perspective Read More
Analysis and Commentary STEVEN GROSSMAN 5/19/23 Analysis and Commentary STEVEN GROSSMAN 5/19/23 The Macro- and Micro- Budget Processes and Their Impact on FDA Resources Read More
Analysis and Commentary STEVEN GROSSMAN 5/12/23 Analysis and Commentary STEVEN GROSSMAN 5/12/23 FDA and the Iron Triangle of Deficit Reduction Read More
Analysis and Commentary STEVEN GROSSMAN 5/5/23 Analysis and Commentary STEVEN GROSSMAN 5/5/23 Hill Days and the Bumpy FY 24 Appropriations Cycle Read More
Analysis and Commentary STEVEN GROSSMAN 4/28/23 Analysis and Commentary STEVEN GROSSMAN 4/28/23 Top Ten Challenges Facing FDA Read More
Analysis and Commentary STEVEN GROSSMAN 4/21/23 Analysis and Commentary STEVEN GROSSMAN 4/21/23 Q&A About FDA and the FY 24 Budget/Appropriations Process Read More
Analysis and Commentary STEVEN GROSSMAN 4/14/23 Analysis and Commentary STEVEN GROSSMAN 4/14/23 Alliance Testifies to the House and Senate on FY 24 Appropriations Read More
Analysis and Commentary STEVEN GROSSMAN 4/6/23 Analysis and Commentary STEVEN GROSSMAN 4/6/23 FDA’s FY 24 Budget Q&A Read More
Analysis and Commentary STEVEN GROSSMAN 3/31/23 Analysis and Commentary STEVEN GROSSMAN 3/31/23 Why Participate In Hill Days Read More
Analysis and Commentary STEVEN GROSSMAN 3/24/23 Analysis and Commentary STEVEN GROSSMAN 3/24/23 Answers to Your Questions about FY24 Appropriation Read More
Analysis and Commentary STEVEN GROSSMAN 3/17/23 Analysis and Commentary STEVEN GROSSMAN 3/17/23 Alliance Seeks Input on FDA Budget Read More
Analysis and Commentary STEVEN GROSSMAN 3/10/23 Analysis and Commentary STEVEN GROSSMAN 3/10/23 More Details on the Administration’s FDA Budget Read More
Analysis and Commentary STEVEN GROSSMAN 3/3/23 Analysis and Commentary STEVEN GROSSMAN 3/3/23 Looking Ahead to the President’s Budget, Part II Read More
Analysis and Commentary STEVEN GROSSMAN 3/1/23 Analysis and Commentary STEVEN GROSSMAN 3/1/23 Looking Ahead to the Presidents FY24 Budget Request Read More
Analysis and Commentary STEVEN GROSSMAN 2/17/23 Analysis and Commentary STEVEN GROSSMAN 2/17/23 What Dr. Califf Told Us During His Fireside Chat Read More
Analysis and Commentary STEVEN GROSSMAN 2/10/23 Analysis and Commentary STEVEN GROSSMAN 2/10/23 Q&A on Medical and Food Safety Advocacy Read More
Analysis and Commentary STEVEN GROSSMAN 2/3/23 Analysis and Commentary STEVEN GROSSMAN 2/3/23 The President’s FY24 Budget Request and the Appropriations Cycle Read More
Analysis and Commentary STEVEN GROSSMAN 1/27/23 Analysis and Commentary STEVEN GROSSMAN 1/27/23 What the Alliance Told the Commissioner About Food Safety Read More
Analysis and Commentary STEVEN GROSSMAN 1/20/23 Analysis and Commentary STEVEN GROSSMAN 1/20/23 What is the Latest in FDA Policy, Legislation, and International Affairs? Read More
Analysis and Commentary STEVEN GROSSMAN 1/13/23 Analysis and Commentary STEVEN GROSSMAN 1/13/23 A Separate Food Agency? Read More
